Immunohistochemical study of an anti-apoptotic protein survivin in lung cancer

Japanese Journal of Lung Cancer

Volumn 49, Issue 1, 2009, Pages 12-16

  Hoshil, Fumihiko ^a   Endo, Chiaki ^a   Sakurada, Akira ^a   Matsumura, Yuji ^a   Okada, Yoshinori ^a   Hoshikawa, Yasushi ^a   Sado, Tetsu ^a   Noda, Masafumi ^a   Kondo, Takashi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Immunohistochemisiry; Non small cell lung cancer; Prognostic factor; Survivin

Indexed keywords

PROTEIN P53; SURVIVIN;

AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEUS ACCUMBENS; PROGNOSIS; PROTEIN EXPRESSION; UNIVERSITY HOSPITAL;

EID: 65649121933     PISSN: 03869628     EISSN: None     Source Type: Journal    
DOI: 10.2482/haigan.49.12     Document Type: Article

References (27)

1. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997:3:917-921. (Pubitemid 27353455)
2. Kennedy SM, O'Driscoll L, Purcell R, Fitz-Simons N, McDermott EW, Hill AD, et al. Prognostic importance of survivin in breast cancer. Br J Cancer. 2003:88:1077-1083. (Pubitemid 36560779)
3. Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, Heine B, Stein H, Hopfner M, et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer. 2003;88:115-119. (Pubitemid 36241227)
4. Mega S, Miyamoto M, Li L, Kadoya M, Takahashi R, Hase R, et al. Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma. Dis Esophagus. 2006;19:355-359. (Pubitemid 44390441)
5. Moon WS, Tarnawski AS. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth? Hum Pathol 2003;34:1119-1126. (Pubitemid 37466997)
6. Ito T. Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K. Ito M. et al. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology. 2000:31:1080-1085. (Pubitemid 30233232)
7. Lu B, Gonzalez A. Massion PP. Shyr Y. Shaktour B, Carbone DP, et al. Nuclear survivin as a biomarker for non-small-cell lung cancer. Br J Cancer. 2004:91:537-540. (Pubitemid 39093575)
8. Tanabe H, Yagihashi A. Tsuji N, Shijubo Y, Abe S. Watanabe N. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Lung Cancer. 2004; 46:299-304. (Pubitemid 39487304)
9. Nakano J. Huang CL, Liu D, Ueno M, Sumitomo S, Yokomise H. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non- small cell lung cancer. Int J Oncol. 2005:27:1215-1221.
10. Vischioni B, van der Valk P. Span SW, Kruyt FA, Rodriguez JA, Giaccone G. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann OncoL 2004:15: 1654-1660. (Pubitemid 39562606)
11. Shinohara ET, Gonzalez A, Massion PP, Chen H, Li M, Freyer AS, et al. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer. 2005;103:1685-1692. (Pubitemid 40490030)
12. Li F, Yang J, Ramnath N, Javle MM. Tan D. Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer. 2005:114:509-512. (Pubitemid 40349608)
13. Akyurek N, Memis L, Ekinci O, Kokturk N. Ozturk C. Survivin expression in pre-invasive lesions and non- small cell lung carcinoma. Virchows Arch. 2006;449:164-170.
14. Tsuji N, Furuse K, Asanuma K, Furuya M, Kondoh K. Kamagata C, et al. Mutations of the p53 gene and loss of heterozygosity at chromosome 17 p 13.1 are associated with increased survivin expression in breast cancer. Breast Cancer Res Treat 2004;87:23-31.
15. Li F. Survivin study: what is the next wave? / Cell Physiol 2003:197:8-29. (Pubitemid 37486223)
16. Cohen C, Lohmann CM, Cotsonis G, Lawson D, Santoianni R. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis. Mod Pathol 2003;16:574-583. (Pubitemid 36718439)
17. Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M. et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Leu. 2001;163:109-116. (Pubitemid 32121836)
18. Lehner R. Lucia MS. Jarboe EA, Orlicky D, Shroyer AL. McGregor JA. et al. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol MorphoL 2002;10:134-138. (Pubitemid 34553169)
19. Atikcan S. Unsal E, Demirag F, Koksal D. Yilmaz A. Correlation between survivin expression and prognosis in non-small cell lung cancer. RespirMed 2006;100:2220-2226.
20. Vegran F. Boidot R, Oudin C, Defrain C, Rebucci M. Lizard-Nacol S. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer. Oncogene. 2007;26:290-297. (Pubitemid 46095740)
21. Hoffman WH, Biade S. Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53./Biol Chem. 2002;277:3247-3257.
22. Caldas H, Honsey LE, Altura RA. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies. Mol Cancer. 2005:4:11. (Pubitemid 41460847)
23. Vegran F. Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S. Distinct expression of Survivin splice variants in breast carcinomas. Int J Oncol 2005;27:1151-1157.
24. Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 1999:59:6097-6102. (Pubitemid 30035627)
25. Mahotka C, Liebmann J, Wenzel M, Suschek CV. Schmitt M, Gabbert HE, et al. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ. 2002;9:1334-1342. (Pubitemid 36097703)
26. Bria E, Visca P, Novelli F, Casini B, Diodoro MG, Perrone-Donnorso R, et al. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer. Ear J Surg Oncol 2008; 34:593-598. (Pubitemid 350265823)
27. Rodriguez JA, Span SW, Ferreira CG, Kruyt FA, Giaccone G. CRMl-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Exp Cell Res. 2002;275:44-53.